Daily Business News - 31st October 2021

Rise of Inflation

Be it fuel prices, cost of transportation, commodity cost, inflation is on the rise and everything is crawling up. Companies that are consumer facing have to raise their price since cost of the input have been hiked.

Unfortunately for companies it is not that easy, they cant get away with rising price because that would hurt their customer portfolio but if they don't their margins are going suffer.

Pre IPO PayTM

Starting of as a product just to put balance on your mobile phone, PayTM sure has achieved a lot. Not just charging utility, it evolved into digital wallet while also cornering E-commerce.

Its hot red in market right now and it has caught a lot of attention due to its upcoming IPO.

Comments

The Asian Paints Price Hike Stroke

This paint business, which was once a stock market favourite, hasn't had a fantastic year. While the Sensex has increased by more than 50%, Asian Paints has only increased by 30%. The Synopsis Asian Paints, the world's largest paint manufacturer, has raised prices by just 3% a year for the past 20 years. That's correct, despite the fact that we've had to cope with out-of-control inflation everywhere, paint costs have never been an issue. The corporation, on the other hand, has finally rolled up its sleeves and is getting down to work. Asian Paints, the industry leader, is raising prices by 7–10 percent starting November 12th. Yes, it's advising everyone to spruce up their homes before Diwali. But, you may wonder, why the abrupt change of heart. Of sure, earnings are important. Sales increased by 32% year over year, from Rs 5,350 crores to almost Rs 7,000 crores, according to the company's latest figures (July-September). However, its net income dropped by 28%, f...

Pharm Easy: A Mini Portfolio

Indian Digital healthcare platform Pharm Easy became the latest startup business in our country and listed in domestic market. Pharm Easy provide health service ranging from tele-communication to radiology test and provide home delivery of medical products. When we compare the past 3months sales of the company, now the monitary value of sales of the company stood at 30.26 billion Rupees. Pharmacy’s company may consider a private issuance of shares worth up to 12.50 billion rupees. Naspers, a technology-focused investor, as well as organizations connected with global investment group CDPQ and private equity firm TPG, are among the company's investors. The company acquired thyrocare technologies, India's leading diagnostic test provider, in order to diversify its operations. The IPO filing for pharmeasy comes on the same day as Nykaa, an Indian fashion e-commerce firm, is scheduled to debut on the stock exchange, and Paytm, a finance...

What Else

Search This Blog